
Aveanna Healthcare Holdings' AVAH.O shares rise 17.1% to $4.38 during pre-market trading
Atlanta-based company expects FY25 rev to be between $2.10 - $2.12 billion, mid-point of which is in line with analysts' estimates of $2.11 billion - LSEG
Co posts Q4 revenue of $519.9 million, beating analyst estimates of $499.6 million
"We expect continued organic volume growth, improved clinical outcomes, and enhanced profitability into 2025" - CFO Matt Buckhalter
Including session's gain, co's shares down about 18% YTD